Work employing various genetically deficient mouse models has shown the critical role of the RANKL–RANK–OPG system plays in bone and immunity – significantly contributing to the emergence of the field of osteoimmunology – as well as organogenesis, and disease conditions including cancer and rheumatoid arthritis (RA). Here, TNFRSF11A is linked to cancer.